The mitochondrial succinate dehydrogenase (SDH) is an essential component of the electron transport chain and of the tricarboxylic acid cycle. Also known as complex II, this tetrameric enzyme catalyzes the oxidation of succinate to fumarate and reduces ubiquinone. Mutations in the human SDHB, SDHC, and SDHD genes are tumorigenic, leading to the development of several types of tumors, including paraganglioma and pheochromocytoma. The mechanisms linking SDH mutations to oncogenesis are still unclear. In this work, we used the yeast SDH to investigate the molecular and catalytic effects of tumorigenic or related mutations. We mutated Arg 47 of the Sdh3p subunit to Cys, Glu, and Lys and Asp 88 of the Sdh4p subunit to Asn, Glu, and Lys. Both Arg 47 and Asp 88 are conserved residues, and Arg 47 is a known site of cancer causing mutations in humans. All of the mutants examined have reduced ubiquinone reductase activities. The SDH3 R47K, SDH4 D88E, and SDH4 D88N mutants are sensitive to hyperoxia and paraquat and have elevated rates of superoxide production in vitro and in vivo. We also observed the accumulation and secretion of succinate. Succinate can inhibit prolyl hydroxylase enzymes, which initiate a proliferative response through the activation of hypoxia-inducible factor 1␣. We suggest that SDH mutations can promote tumor formation by contributing to both reactive oxygen species production and to a proliferative response normally induced by hypoxia via the accumulation of succinate.The mitochondrial succinate dehydrogenase (SDH, also known as complex II or succinate:ubiquinone oxidoreductase) 4 is a critical enzyme linking the mitochondrial respiratory chain and the tricarboxylic acid cycle. SDH is an iron-sulfur flavoprotein that resides in the mitochondrial inner membrane and functions to oxidize succinate to fumarate and reduce ubiquinone (Q) to ubiquinol (1-3). The yeast SDH, like its mammalian counterpart, consists of four nuclear encoded subunits (Sdh1p-Sdh4p in yeast and SDHA-SDHD in mammals) (2), a covalently attached flavin adenine dinucleotide (FAD) (4), three iron-sulfur centers, a b-type heme, and two ubiquinone-binding sites referred to as the proximal and distal sites (Q P and Q D ), respectively (5, 6). Sdh1p and Sdh2p form the catalytic domain, the site of succinate oxidation. Electrons flow through the catalytic domain to the membrane domain, consisting of Sdh3p and Sdh4p, where quinone reduction occurs.Mutations in the human SDHA gene can result in Leigh syndrome, an infantile-onset progressive neurodegenerative disease (7,8). Mutations in the human SDHB, SDHC, and SDHD genes lead to inheritable forms of cancer such as pheochromocytomas (catechol-secreting tumors commonly occurring in the adrenal medulla), paragangliomas (benign vascularized tumors in the head and neck), and renal cell carcinoma (9 -11). More recently, it was reported that loss of the SDHD gene may contribute to gastric and colon cancers (12). These observations highlight the importance of SDH genes as mitochondrial tumor suppre...